Status: Recruiting
CAR BCMA-70 CAR-T Cells for the Treatment of High-risk Plasma Cell Neoplasms
This is a single arm study to evaluate the safety and efficacy of CAR BCMA-CD70 CAR-T cell therapy for high-risk plasma cell neoplasms.
Participants needed: 20
Trial details
Phase: Early Phase 1Age: 18-75Biological sex: AllType: InterventionalSponsor: Affiliated Hospital to Academy of Military Medical SciencesUpdated: Jul 13, 2026Locations: 1
Eligibility criteria
The subject or their legally acceptable representative has provided written info... [+13]
Severe cardiac insufficiency with left ventricular ejection fraction (LVEF%) < 5... [+10]